Profile | GDS4284 / 230252_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 8944.99 | 97 |
GSM687648 | Patient 402 control | 8424.65 | 96 |
GSM687653 | Patient 403 control | 8000.08 | 96 |
GSM687658 | Patient 404 control | 9302.66 | 97 |
GSM687663 | Patient 411 control | 7699.91 | 96 |
GSM687668 | Patient 422 control | 6132.29 | 95 |
GSM687673 | Patient 424 control | 7255.9 | 96 |
GSM687678 | Patient 425 control | 6638.68 | 95 |
GSM687683 | Patient 427 control | 7112.97 | 96 |
GSM687688 | Patient 428 control | 8192.38 | 96 |
GSM687695 | Patient 441 control | 2448.68 | 88 |
GSM687699 | Patient 443 control | 4453.59 | 93 |
GSM687704 | Patient 444 control | 9815.07 | 97 |
GSM687707 | Patient 448 control | 13867.6 | 98 |
GSM687712 | Patient 449 control | 9510.04 | 97 |
GSM687719 | Patient 450 control | 5565.26 | 94 |
GSM687724 | Patient 451 control | 6839.1 | 95 |
GSM687728 | Patient 452 control | 5480.53 | 94 |
GSM687646 | Patient 401 treated 24h | 7036.48 | 96 |
GSM687649 | Patient 402 treated 24h | 7476.77 | 96 |
GSM687665 | Patient 411 treated 24h | 8853.56 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 8018.68 | 96 |
GSM687667 | Patient 411 treated 4 weeks | 8323.85 | 96 |
GSM687670 | Patient 422 treated 24h | 6034.79 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 6481.91 | 95 |
GSM687654 | Patient 403 treated 24h | 6828.41 | 95 |
GSM687675 | Patient 424 treated 24h | 7662.86 | 96 |
GSM687685 | Patient 427 treated 24h | 5224.54 | 94 |
GSM687656 | Patient 403 treated 4 weeks | 8271.3 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 9068.28 | 97 |
GSM687687 | Patient 427 treated 4 weeks | 7177.94 | 96 |
GSM687692 | Patient 428 treated 4h | 6504.84 | 95 |
GSM687716 | Patient 449 treated 4h | 9012.48 | 97 |
GSM687722 | Patient 450 treated 4h | 5591.54 | 94 |
GSM687680 | Patient 425 treated 24h | 6800.17 | 95 |
GSM687690 | Patient 428 treated 24h | 7418.38 | 96 |
GSM687700 | Patient 443 treated 24h | 4257.34 | 93 |
GSM687705 | Patient 444 treated 24h | 7857.82 | 96 |
GSM687714 | Patient 449 treated 24h | 8357.96 | 96 |
GSM687721 | Patient 450 treated 24h | 4309.18 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 6752.52 | 95 |
GSM687694 | Patient 428 treated 4 weeks | 6847.75 | 95 |
GSM687702 | Patient 443 treated 4 weeks | 6855.91 | 95 |
GSM687718 | Patient 449 treated 4 weeks | 10010.7 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 6429.47 | 95 |
GSM687661 | Patient 404 treated 4h | 10383.3 | 97 |
GSM687710 | Patient 448 treated 4h | 14337.7 | 98 |
GSM687726 | Patient 451 treated 4h | 6291.35 | 95 |
GSM687730 | Patient 452 treated 4h | 14421.8 | 98 |
GSM687660 | Patient 404 treated 24h | 4778.65 | 93 |
GSM687697 | Patient 441 treated 24h | 4037.04 | 92 |
GSM687709 | Patient 448 treated 24h | 13853.6 | 98 |
GSM687725 | Patient 451 treated 24h | 5869.88 | 95 |
GSM687729 | Patient 452 treated 24h | 3085.21 | 90 |
GSM687727 | Patient 451 treated 4 weeks | 7422.77 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 5460.06 | 94 |